InvestorsHub Logo
Followers 60
Posts 7394
Boards Moderated 0
Alias Born 10/20/2014

Re: swg_tdr post# 406160

Thursday, 03/23/2023 9:48:26 AM

Thursday, March 23, 2023 9:48:26 AM

Post# of 426251
Swg_tdr, My belief is that Vascepa "could" have a massive market in China "if"
AMRN had the right acquirer who had the resources to capitalize on the need
in that nation. China has a graying population that makes them more vulnerable
to CVD. Even if Vascepa were just a drug for the elite there that would still be a
massive market. If AMRN were owned by a BP that could establish itself as
the leader for an effective Omega-3 CVD medication, and one that could keep
potential competitors at bay, (with or without Eddingpharms involvement...That
would be a gamechanger!
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News